Article info
PDFClinical and epidemiological research
Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol
- M K Reinders, Department of Clinical Pharmacy, Atrium Medisch Centrum Parkstad, PO Box 4446, 6401 CX Heerlen, The Netherlands; m.reinders{at}atriummc.nl
Citation
Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol
Publication history
- Accepted January 17, 2008
- First published February 4, 2008.
Online issue publication
November 02, 2019
Article Versions
- Previous version (2 November 2019).
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group and European League Against Rheumatism